These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38708489)

  • 1. The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Indicator of Mortality in Pediatric Septic Shock.
    Turan C; Yurtseven A; Ozkaya PY; Azarsiz E; Saz EU
    J Clin Lab Anal; 2024 May; 38(9):e25040. PubMed ID: 38708489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor.
    Giamarellos-Bourboulis EJ; Norrby-Teglund A; Mylona V; Savva A; Tsangaris I; Dimopoulou I; Mouktaroudi M; Raftogiannis M; Georgitsi M; Linnér A; Adamis G; Antonopoulou A; Apostolidou E; Chrisofos M; Katsenos C; Koutelidakis I; Kotzampassi K; Koratzanis G; Koupetori M; Kritselis I; Lymberopoulou K; Mandragos K; Marioli A; Sundén-Cullberg J; Mega A; Prekates A; Routsi C; Gogos C; Treutiger CJ; Armaganidis A; Dimopoulos G
    Crit Care; 2012 Aug; 16(4):R149. PubMed ID: 22873681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.
    El-Mekkawy MS; Saleh NY; Sonbol AA
    Indian J Pediatr; 2016 Jul; 83(7):661-9. PubMed ID: 26960717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis.
    Okulu E; Arsan S; Akin IM; Ates C; Alan S; Kilic A; Atasay B
    J Clin Lab Anal; 2015 Sep; 29(5):347-52. PubMed ID: 25043869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
    Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
    J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin induces soluble urokinase-type plasminogen activator receptor production and release.
    Vaschetto R; Navalesi P; Clemente N; Boggio E; Valsecchi S; Olivieri C; Soluri MF; Kroumova V; Fonio P; Dinatale C; Borrè S; Fortina G; Umberto D; Della Corte F; Chiocchetti A
    Minerva Anestesiol; 2015 Feb; 81(2):157-65. PubMed ID: 24994498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) compared to C-reactive protein (CRP) and procalcitonin (PCT) in children with systemic inflammatory response syndrome (SIRS).
    Şirinoğlu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Yalındağ-Öztürk N; Cinel İ; Yaman A; Haklar G; Şirikci Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
    J Infect Chemother; 2017 Jan; 23(1):17-22. PubMed ID: 27771157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombo-inflammatory biomarkers to predict sepsis outcome.
    Efat A; Shoeib SA; Arafa AF; Dawod AA; Abd ElHafez MA; Abd ElMohsen EA; Eladly HF; Ibrahim RA; Elkholy A
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048561. PubMed ID: 34647483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of plasma soluble urokinase-type plasminogen activator receptor levels in term neonates with infection or sepsis: a prospective study.
    Siahanidou T; Margeli A; Tsirogianni C; Charoni S; Giannaki M; Vavourakis E; Charisiadou A; Papassotiriou I
    Mediators Inflamm; 2014; 2014():375702. PubMed ID: 24882949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.
    Uusitalo-Seppälä R; Huttunen R; Tarkka M; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
    J Intern Med; 2012 Sep; 272(3):247-56. PubMed ID: 22755554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study.
    Polzik P; Grøndal O; Tavenier J; Madsen MB; Andersen O; Hedetoft M; Hyldegaard O
    Sci Rep; 2019 Mar; 9(1):5098. PubMed ID: 30911053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparative Study of the Diagnostic and Prognostic Utility of Soluble Urokinase-type Plasminogen Activator Receptor and Procalcitonin in Patients with Sepsis and Systemic Inflammation Response Syndrome.
    Sharma A; Ray S; Mamidipalli R; Kakar A; Chugh P; Jain R; Ghalaut MS; Choudhury S
    Indian J Crit Care Med; 2020 Apr; 24(4):245-251. PubMed ID: 32565634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic power of soluble urokinase plasminogen activator receptor (suPAR) for short-term mortality in patients seen in Emergency Departments due to infections].
    Rubio Díaz R; de Rafael González E; Martín Torres E; Valera Núñez E; López Martos AM; Melguizo Melguizo D; Picazo Perea MP; López García PJ; Fuentes Bullejos P; Chafer Rudilla M; Carretero Gómez JF; Julián-Jiménez A
    Rev Esp Quimioter; 2022 Feb; 35(1):50-62. PubMed ID: 34859658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of soluble urokinase plasminogen activator receptor compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
    Sirinoglu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Cinel I; Koç A; Tokuç G; Yaman A; Haklar G; Şirikçi Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
    Pediatr Hematol Oncol; 2016 Apr; 33(3):200-8. PubMed ID: 27057782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
    Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
    Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.
    Savva A; Raftogiannis M; Baziaka F; Routsi C; Antonopoulou A; Koutoukas P; Tsaganos T; Kotanidou A; Apostolidou E; Giamarellos-Bourboulis EJ; Dimopoulos G
    J Infect; 2011 Nov; 63(5):344-50. PubMed ID: 21839112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the emergency department with chest pain suggestive of acute coronary syndrome.
    Chenevier-Gobeaux C; Lemarechal H; Doumenc B; Peschanski N; Claessens YE; Borderie D; Ray P
    Clin Biochem; 2021 Jun; 92():19-24. PubMed ID: 33662350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers as Predictors of Mortality in Sepsis and Septic Shock for Patients Admitted to Emergency Department: Who Is the Winner? A Prospective Study.
    Luka S; Golea A; Tat RM; Lupan Mureșan EM; Voicescu GT; Vesa ȘC; Ionescu D
    J Clin Med; 2024 Sep; 13(19):. PubMed ID: 39407738
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
    Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
    Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
    Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
    J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.